Active Ingredient: Ambroxol, Albuterol
Dosage: 60 ml
Route of Administration: Oral
Dosage Form: Suspension
Quantity per package: 1 unit
Availability: Out of stock
Broxol Air is a combination of salbutamol and ambroxol. It is a bronchodilator and mucolytic. The drug is indicated in acute and chronic bronchitis, asthma and in general in those acute and chronic processes that occur with retention of secretions and bronchospasm.
Broxol Air is currently unavailable for the purchase but there are many worthy analogs of this medication.
This drug is used to treat acute bronchitis, chronic bronchitis, bronchial asthma and all those acute and chronic processes that occur with secretion retention and bronchospasm.
Dosage and administration
- 2-4 years, 12 to 16 kg: 3 ml every 8 hours. Maximum dose 6 ml every 8 hours;
- 4-6 years, 16 to 22 kg: 4 ml every 8 hours. Maximum dose 8 ml every 8 hours;
- Over 6 years and adults: 5 ml every 8 hours. Maximum dose 10 ml every 8 hours.
Each dose of 5 ml is equivalent to 7.5 mg of ambroxol and 2 mg of salbutamol.
Broxol Air is contraindicated in the presence of any of the following conditions:
- hypersensitivity to the components of the formula,
- gastric ulcer;
- arterial hypertension;
- heart failure;
- use of MAO inhibitors, propranolol, beta-blockers.
Ambroxol can cause mild gastrointestinal disorders such as diarrhea, nausea, vomiting, headache. Salbutamol can produce fine tremors, nervousness, palpitations, depending on the dose administered and/or in patients hypersensitive to the active substance.
Cases of overdose with Broxol Air have not been reported.
Ambroxol can be administered concomitantly with other medications such as amoxicillin, cephalexin, gentamicin, tobramycin, sisomicin, amikacin, kanamycin, thiamphenicol, carbenicillin or with analgesics, anti-inflammatories, among others.